23m
Hosted on MSNNovavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi PartnershipNovavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...
Phil Mounteney, who is Dotmatics' vice president of science and technology, says the pandemic showed more relaxed regulations ...
Fewer Canadians received the influenza vaccination this year than in prior years, in a trend one infectious disease expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results